| Ytd | -4.26% | |
| 1y | -21.40% |
| Open | Prev Close | 1.80 | Low | High | Mkt Cap | 212.83M | |||
| Vol | 0.00 | Avg Vol | 1.39M | EPS | -0.60 | P/E | -3.00 | Forward P/E | -39.70 |
| Beta | -0.12 | Short Ratio | 4.26 | Inst. Own | 26.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-13 | 50-d Avg | 1.63 | 200-d Avg | 1.66 | 1yr Est | 5.76 |
WALD News
LONDON, June 15, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Compan
LONDON, June 01, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or “the Compan
Data from the ALOHA Program and NU-GEN™ Cellular Renewal Serum Showcase Results to Help Drive Practi
A multi-city pop-up introducing consumers to the future of skincare and longevity innovation A multi
Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 delivers advanced mineral protection wi
Seagate Technology Holdings (STX) shares rose 18% in pre-market trading after reporting strong Q3 re
LONDON, April 28, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Compa
Waldencast PLC (NASDAQ: WALD - Get Free Report) saw a significant increase in short interest during
The clinically proven formula pairs NAD+ with its precursors to replenish skin cells and address nin
ProMD's multi-location physician led network will participate in Obagi's ALOHA Program as part of a
Shares of Waldencast PLC (NASDAQ: WALD - Get Free Report) have received an average rating of "Modera
FY 2025 net revenue of $272.1 million, flat to FY 2024, and Adjusted EBITDA of $16.1 million Q4 2025
LONDON, March 11, 2026 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global m
Schweiger selected as a leading dermatology platform partner due to its commitment to clinical excel
It's a Secret Med Spa selected as a premier luxury med spa partner due to its commitment to excellen
Aesthetic Record selected as a leading aesthetics EMR and practice management partner due to its com
Shares of Waldencast PLC (NASDAQ: WALD - Get Free Report) have received an average recommendation of
DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient c
Moxie selected as a leading aesthetic practice software and support partner for its commitment to in
The dermatologist-tested duo pairs gentle chemical resurfacing with daily hydration and SPF protecti
VIO Med Spa selected as a key med spa franchise partner for its commitment to clinical excellence, i
